Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 mutations occur in clinical, but not latent, human prostate carcinoma.

Japanese journal of cancer research : Gann - 1 Jan 1995

Konishi N, Hiasa Y, Hayashi I, Matsuda H, Tsuzuki T, Ming T, Kitahori Y, Shiraishi T, Yatani R, Shimazaki J

Abstract excerpt

To elucidate the role of the p53 tumor suppressor gene in prostate tumorigenesis, we probed for mutations in latent and clinical prostate cancers using single strand conformation polymorphism (SSCP) and restriction fragment length polymorphism (RFLP) analysis in combination with direct gene sequencing and immunohistochemical methodologies. Fifteen cases of subclinical and 32 cases of clinical carcinoma, the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Sequence
Share to Genes, p53
Share to Immunohistochemistry

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Molecular Sequence Data

Share to Mutation

Share to Polymerase Chain Reaction

Share to Polymorphism, Restriction Fragment Length

Share to Sequence Analysis, DNA

Source

Open in PubMed Open full text

Identifiers

PMID: 7737911
DOI: 10.1111/j.1349-7006.1995.tb02988.x
PMCID: PMC5920585

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 mutations occur in clinical, but not latent, human prostate carcinoma.PMID 7737911Read ↗

p53 gene alterations in human prostate carcinoma.Semantic proximity Read ↗

Tumor suppressor gene p53 mutations in human prostate cancer.Semantic proximity Read ↗

Abnormal p53 expression is rare in clinically localized human prostate cancer: comparison between immunohistochemical and molecular detection of p53 mutations.Semantic proximity Read ↗

Frequency and characterization of p53 mutations in clinically localized prostate cancer.Semantic proximity Read ↗

p53 oncogene mutations in human prostate cancer specimens.Semantic proximity Read ↗

Alterations of p53 are common in early stage prostate cancer.Semantic proximity Read ↗

Alterations of the P53 gene are associated with the progression of a human prostate carcinoma.Semantic proximity Read ↗

An uncertain role for p53 gene alterations in human prostate cancers.Semantic proximity Read ↗

Differences in the p53 gene mutational spectra of prostate cancers between Japan and Western countries.Semantic proximity Read ↗

p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potential.Semantic proximity Read ↗

p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.Semantic proximity Read ↗

Frequency and characterization of p53 mutations in primary and metastatic human prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.